Business

Cramer’s lightning round: Hims & Hers Health is not a buy

Loading chart…

Hims & Hers Health Inc: “Hims & Hers lose money … I’m not recommending stocks that are losing a lot of money.”

Loading chart…

Two Harbors Investment Corp: “I’m not going there. We’ve seen a lot of companies like that. … I’m not playing.”

Loading chart…

Shell Midstream Partners LP: “[Enterprise Product Partners], that’s the best one if you want to be in that group now.”

Loading chart…

Healthcare Realty Trust Inc: “I thought [the company’s merger with Healthcare Trust of America] made a lot of sense. … I like it.”

Loading chart…

DraftKings Inc: “[Kynikos Associates founder] Jim Chanos says it’s a great short. I think the time to short the stock was much, much higher.”

Loading chart…

Gilead Sciences Inc: “I know it looks very, very cheap. But you know what, that’s not why we buy drugs stocks. We buy drug stocks because they’ve got growth, and Gilead has none.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Products You May Like

Articles You May Like

The jet-tracking teen stopped tweeting Mark Cuban’s flights for free, but refused $5,000 from Elon Musk for the same thing
Stocks making the biggest moves midday: Lyft, Carvana, Warner Bros. Discovery, DraftKings
Biden has promised a student loan forgiveness decision this month. Here are 5 things borrowers can do while they wait
More Americans are working part-time — a potential harbinger of future jobs market instability
As climate change threatens more homes, some properties are getting too costly to insure

Leave a Reply

Your email address will not be published.